Tag Archives: failure to warn

Generic drug maker faces liability for out-of-date warning label

Federal law does not preempt a product liability suit alleging that the maker of a generic form of Fosamax failed to update its warning label in conformity with revised brand-name warnings, the California Court of Appeal has ruled in affirming ...

Read More »

Calif. judge tosses $6.5M verdict in first Actos trial

A California judge has thrown out a $6.5 million product liability verdict against Takeda Pharmaceuticals, deciding that a key expert witness should not have been allowed to testify that the diabetes drug Actos was the cause of a man’s bladder ...

Read More »

Fla. jury awards $250K in Zometa jaw injury suit

A federal jury has awarded $250,000 to a Florida couple who claimed Novartis Pharmaceuticals failed to adequately warn of the risk of osteonecrosis of the jaw from taking the bone strengthening drug Zometa. J. Hunter Chiles III will received $200,000 ...

Read More »

Mass. jury awards $63M for child’s reaction to Motrin

A Massachusetts jury awarded $63 million to a teenaged girl and her parents after the girl suffered an adverse reaction to Children’s Motrin that left her scarred and blind, with permanent brain and lung damage. And the award may increase.

Read More »

Medtronic pain pump claim isn’t preempted

Federal law does not preempt a state failure-to-warn lawsuit brought by a man who claimed he suffered paralysis as the result of the surgical implantation of a Medtronic pain pump, the en banc 9th Circuit has ruled. The decision overturns ...

Read More »

Class action alleges deceptive marketing of Monster Energy drinks

Monster-brand energy drinks are marketed as being conventional carbonated beverages despite containing “dangerously high” amounts of caffeine, according to a new consumer class action filed in California federal court.

Read More »